Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marek Kovar

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Oncoimmunology|May 4, 2016
IL-2/anti-IL-2 mAb immunocomplexes: A renascence of IL-2 in cancer immunotherapy?Jakub Tomala, Marek Kovar
Immunology Letters|February 12, 2014
Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimeraPetra Votavova, Jakub Tomala, Marek Kovar
World Journal of Microbiology & Biotechnology|August 30, 2021
Nickel induced cell impairments are negatively regulated by the Tor1 kinase in Schizosaccharomyces pombeAlica Navratilova, Marek Kovar, Anna Trakovicka, et al.
Trends in Immunology|October 12, 2023
IL-2-driven CD8<sup>+</sup> T cell phenotypes: implications for immunotherapyVeronika Niederlova, Oksana Tsyklauri, Marek Kovar, et al.
Cytokine|June 30, 2020
IL-7/αIL-7 mAb M25 immunocomplexes expand CD8<sup>+</sup> T cells but paradoxically abrogate the antitumor activity of CTLA-4 and PD-1 blockageDominik Hrabos, Tereza Hnizdilova, Jakub Tomala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2009
In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapyJakub Tomala, Helena Chmelova, Tomas Mrkvan, et al.
Minerva Anestesiologica|December 17, 2020
Intra- and interobserver agreement of rectus femoris cross-sectional area in critically ill patientsOndrej Hrdy, Kamil Vrbica, Marek Kovar, et al.
Expert Opinion on Investigational Drugs|June 1, 2026
SOT201: <i>cis</i>-acting PD-1/IL-15 mutein-based immunocytokine under investigational study in solid tumorsVladyslav Mazhara, Irfan Baki Kilic, Irena Adkins, et al.
Plant, Cell & Environment|March 28, 2025
Beyond Photosynthetic Active Radiation: The Role of Far-Red Energy and Signalling in the Improvement of PhotosynthesisAida Shomali, Yousef Yari Kamrani, Marek Zivcak, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2006
Direct stimulation of T cells by membrane vesicles from antigen-presenting cellsMarek Kovar, Onur Boyman, Xuefei Shen, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Oncoimmunology|May 4, 2016
IL-2/anti-IL-2 mAb immunocomplexes: A renascence of IL-2 in cancer immunotherapy?Jakub Tomala, Marek Kovar
Immunology Letters|February 12, 2014
Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimeraPetra Votavova, Jakub Tomala, Marek Kovar
World Journal of Microbiology & Biotechnology|August 30, 2021
Nickel induced cell impairments are negatively regulated by the Tor1 kinase in Schizosaccharomyces pombeAlica Navratilova, Marek Kovar, Anna Trakovicka, et al.
Trends in Immunology|October 12, 2023
IL-2-driven CD8<sup>+</sup> T cell phenotypes: implications for immunotherapyVeronika Niederlova, Oksana Tsyklauri, Marek Kovar, et al.
Cytokine|June 30, 2020
IL-7/αIL-7 mAb M25 immunocomplexes expand CD8<sup>+</sup> T cells but paradoxically abrogate the antitumor activity of CTLA-4 and PD-1 blockageDominik Hrabos, Tereza Hnizdilova, Jakub Tomala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2009
In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapyJakub Tomala, Helena Chmelova, Tomas Mrkvan, et al.
Minerva Anestesiologica|December 17, 2020
Intra- and interobserver agreement of rectus femoris cross-sectional area in critically ill patientsOndrej Hrdy, Kamil Vrbica, Marek Kovar, et al.
Expert Opinion on Investigational Drugs|June 1, 2026
SOT201: <i>cis</i>-acting PD-1/IL-15 mutein-based immunocytokine under investigational study in solid tumorsVladyslav Mazhara, Irfan Baki Kilic, Irena Adkins, et al.
Plant, Cell & Environment|March 28, 2025
Beyond Photosynthetic Active Radiation: The Role of Far-Red Energy and Signalling in the Improvement of PhotosynthesisAida Shomali, Yousef Yari Kamrani, Marek Zivcak, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2006
Direct stimulation of T cells by membrane vesicles from antigen-presenting cellsMarek Kovar, Onur Boyman, Xuefei Shen, et al.
Pageof 5